SS Innovations International Files 8-K

Ticker: SSII · Form: 8-K · Filed: 2025-05-14T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, operations, disclosure

TL;DR

SS Innovations dropped an 8-K on 5/14 detailing financials and operations.

AI Summary

SS Innovations International, Inc. filed an 8-K on May 14, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements. The company, formerly known as AVRA Medical Robotics, Inc., is incorporated in Florida and has its principal executive offices in Gurugram, India.

Why It Matters

This 8-K filing provides crucial updates on SS Innovations International's financial performance and operational status, which are important for investors to assess the company's current health and future prospects.

Risk Assessment

Risk Level: medium — As an 8-K filing, it primarily contains factual disclosures about financial condition and operations, but the specific details within the filing could reveal significant positive or negative developments.

Key Players & Entities

FAQ

What specific financial results or operational updates are detailed in this 8-K filing?

The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures or details within the provided text.

When was SS Innovations International, Inc. previously known by another name?

The company was formerly known as AVRA Medical Robotics, Inc., with a date of name change on June 1, 2016.

Where are the principal executive offices of SS Innovations International, Inc. located?

The principal executive offices are located at 405, 3rd Floor, iLabs Info Technology Centre, Udyog Vihar, Phase III, Gurugram, Haryana, India, 122016.

What is the state of incorporation for SS Innovations International, Inc.?

The company is incorporated in Florida.

What items are being reported in this 8-K filing?

This 8-K filing reports on 'Results of Operations and Financial Condition', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits'.

From the Filing

0001213900-25-043384.txt : 20250514 0001213900-25-043384.hdr.sgml : 20250514 20250514164420 ACCESSION NUMBER: 0001213900-25-043384 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250514 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250514 DATE AS OF CHANGE: 20250514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SS Innovations International, Inc. CENTRAL INDEX KEY: 0001676163 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 473478854 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42615 FILM NUMBER: 25946590 BUSINESS ADDRESS: STREET 1: 1600 SE 15TH STREET STREET 2: #512 CITY: FORT LAUDERDALE STATE: FL ZIP: 33316 BUSINESS PHONE: (954) 478-1410 MAIL ADDRESS: STREET 1: 1600 SE 15TH STREET STREET 2: #512 CITY: FORT LAUDERDALE STATE: FL ZIP: 33316 FORMER COMPANY: FORMER CONFORMED NAME: AVRA Medical Robotics, Inc. DATE OF NAME CHANGE: 20160601 8-K 1 ea0242229-8k_ssinnov.htm CURRENT REPORT false 0001676163 0001676163 2025-05-14 2025-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of report (Date of earliest event reported): May 14, 2025   SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter)   Florida   000-56608   47-3478854 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   405, 3 rd Floor , iLabs Info Technology Centre Udyog Vihar, Phase III, Gurugram, Haryana , India   122016 Address of Principal Executive Office (Street and Number)   (Zip Code)   Registrant’s telephone number, including area code: +91 73375 53469       (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each Class   Trading Symbol   Name of each exchange on which registered Common Stock   SSII   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             As used in this Current Report on Form 8-K (this “ Current Report ”), the terms “ SSi ,” “ the Company ,” “ we ,” “ us ” and “ our ” refer to SS Innovations International, Inc. and its subsidiaries.   Item 2.02 Results of O

View on Read The Filing